TP53 and neoplasm: Further analysis was done on baseline tumor samples from 52 patients, of which four (21%) of the 19 patients with tumors harboring TP53 mutation achieved a PR while only four (12%) of the 33 patients with TP53 wild-type tumors achieved a PR [11].